Valuation Black Diamond Therapeutics, Inc.
Stocks
BDTX
US09203E1055
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
06:00:00 02/10/26 am AEST
|
5-day change | 1st Jan Change | ||
| 1.880 USD | -0.27% |
|
-1.05% | -22.63% |
Company Valuation: Black Diamond Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 193.1 | 65.46 | 145.1 | 121.1 | 138.4 | 108.3 | - | - |
| Change | - | -66.1% | 121.66% | -16.54% | 14.33% | -21.78% | - | - |
| Enterprise Value (EV) | -16.69 | -57.35 | 145.1 | 121.1 | 138.4 | 108.3 | 108.3 | 108.3 |
| Change | - | -243.68% | 353.01% | -16.54% | 14.33% | -21.78% | 0% | 0% |
| P/E | -1.54x | -0.71x | -1.49x | -1.69x | 6.23x | -3.06x | -1.98x | -2.04x |
| PBR | 0.98x | - | - | - | - | - | - | - |
| PEG | - | 0x | 0.1x | 0.1x | -0x | 0x | -0x | 0.73x |
| Capitalization / Revenue | - | - | - | - | 1.98x | 17.3x | - | - |
| EV / Revenue | - | - | - | - | 0x | 17.3x | - | - |
| EV / EBITDA | 0x | 0x | - | -0x | 0x | -2.23x | -1.63x | -1.33x |
| EV / EBIT | 0x | 0x | -0x | -0x | 0x | -2.51x | -1.57x | -1.18x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -3.47 | -2.52 | -1.88 | -1.27 | 0.39 | -0.6162 | -0.9525 | -0.9257 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | 70 | 6.25 | - | - |
| EBITDA 1 | -126.7 | -92.32 | - | -78.44 | 20.2 | -48.52 | -66.52 | -81.66 |
| EBIT 1 | -126.9 | -92.83 | -86.46 | -78.78 | 19.87 | -43.14 | -69.02 | -91.83 |
| Net income 1 | -125.6 | -91.17 | -82.44 | -69.68 | 22.37 | -36.96 | -64.65 | -87.39 |
| Net Debt | -209.8 | -122.8 | - | - | - | - | - | - |
| Reference price 2 | 5.330 | 1.800 | 2.810 | 2.140 | 2.430 | 1.885 | 1.885 | 1.885 |
| Nbr of stocks (in thousands) | 36,229 | 36,366 | 51,635 | 56,585 | 56,975 | 57,454 | - | - |
| Announcement Date | 17/3/22 | 9/3/23 | 12/3/24 | 6/3/25 | 16/3/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.06x | - | - | - | 108M | |
| 21.73x | 7.77x | 15.61x | 1.37% | 74.46B | |
| 31.25x | 9.01x | 28.06x | 0.04% | 60.14B | |
| 33.64x | 6.03x | 18.07x | 0.97% | 48.15B | |
| 34.63x | 3.34x | 14.4x | -.--% | 44.25B | |
| -21.16x | 229.18x | -22.81x | -.--% | 43.99B | |
| 47.94x | 5.54x | 30.43x | -.--% | 41.61B | |
| 26.89x | 7.76x | 19.96x | 0.42% | 29.97B | |
| 33.91x | 7.26x | 18.84x | -.--% | 29.31B | |
| -70.02x | 13.44x | -68.51x | -.--% | 24.93B | |
| Average | 13.57x | 32.15x | 6.01x | 0.31% | 39.69B | |
| Weighted average by Cap. | 19.57x | 31.88x | 10.24x | 0.41% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BDTX Stock
- Valuation Black Diamond Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
